Who
Patrick McCall
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, IN8bio.
In numbers
- Trades disclosed
- 29
- Buys
- 2
- Sells
- 0
- Bought
- $11K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Jul 2021
- Last trade
- 9 May 2026
- Last filed
- 12 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 May 2026filed 12 May 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —56,250 at $0.00 | filing |
| 9 May 2026filed 12 May 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —56,250 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | INAB IN8bioBiotechnology | SEC FORM 4 Code A | $10K7,247 at $1.38 | filing |
| 30 Apr 2025filed 7 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 30 Apr 2025filed 7 May 2025 | INAB IN8bioBiotechnology | SEC FORM 4 Code M | $2,70015,000 at $0.18 | filing |
| 27 Apr 2025filed 7 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code D | —15,000 | filing |
| 27 Apr 2025filed 7 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 | filing |
| 27 Apr 2025filed 7 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code D | —20,492 | filing |
| 27 Apr 2025filed 7 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —20,492 | filing |
| 5 Feb 2025filed 7 Feb 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —343,000 at $0.00 | filing |
| 19 Dec 2024filed 23 Dec 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —290,085 at $0.00 | filing |
| 4 Oct 2024filed 8 Oct 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code D | —20,492 | filing |
| 4 Oct 2024filed 8 Oct 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —20,492 | filing |
| 4 Oct 2024filed 8 Oct 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —25,316 | filing |
| 4 Oct 2024filed 8 Oct 2024 | INAB IN8bioBiotechnology | SEC FORM 4 Code A | —25,316 | filing |
| 4 Sep 2024filed 5 Sep 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 7 Feb 2024filed 8 Feb 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —189,000 at $0.00 | filing |
| 13 Dec 2023filed 15 Dec 2023 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —20,492 | filing |
News
No headline names them, or the companies they trade most, lately.